Cargando…

Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma

Glioblastoma (GBM), the most common and malignant brain tumor, is classified according to its isocitrate dehydrogenase (IDH) mutation status in the 2016 World Health Organization (WHO) brain tumor classification scheme. The standard treatment for GBM is maximal resection, radiotherapy, and Temozolom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adilijiang, Alimu, Hirano, Masaki, Okuno, Yusuke, Aoki, Kosuke, Ohka, Fumiharu, Maeda, Sachi, Tanahashi, Kuniaki, Motomura, Kazuya, Shimizu, Hiroyuki, Yamaguchi, Junya, Wakabayashi, Toshihiko, Natsume, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749405/ https://www.ncbi.nlm.nih.gov/pubmed/31443404 http://dx.doi.org/10.3390/molecules24173046

Ejemplares similares

Neurod4 converts endogenous neural stem cells to neurons with synaptic formation after spinal cord injury
por: Fukuoka, Toshiki, et al.
Publicado: (2021)

Multiple metastases to the bone and bone marrow from a 1p/19q-codeleted and IDH2-mutant anaplastic oligodendroglioma: a case report and literature review
por: Shimizu, Hiroyuki, et al.
Publicado: (2020)

NQPC-02 Long-term survival in patients with primary intracranial germ cell tumors treated with surgery, platinum-based chemotherapy, and radiotherapy: a single-institution study
por: Motomura, Kazuya, et al.
Publicado: (2020)

Survival Benefit of Supratotal Resection in a Long-term Survivor of IDH-wildtype Glioblastoma: A Case Report and Literature Review
por: YAMAGUCHI, Junya, et al.
Publicado: (2021)

TB-03 Newly Established Meningioma Organoid Model Elucidated an Important Role of FOXM1 in Meningioma Progression
por: Yamazaki, Shintaro, et al.
Publicado: (2020)

TB-2 Patient-derived meningioma organoid model demonstrates FOXM1 dependent tumor proliferation
por: Yamazaki, Shintaro, et al.
Publicado: (2021)

MPC-5 Characteristics of H3 G34-mutant gliomas
por: Kibe, Yuji, et al.
Publicado: (2021)

H3F3A mutant allele specific imbalance in an aggressive subtype of diffuse midline glioma, H3 K27M-mutant
por: Maeda, Sachi, et al.
Publicado: (2020)

STMO-6 Impact of the extent of resection on the survival of patients with lower grade gliomas using awake brain mapping
por: Motomura, Kazuya, et al.
Publicado: (2021)

MPC-20 CLINICAL AND MOLECULAR FEATURES OF GLIOBLASTOMAS ARISING IN THE SETTING OF LI FRAUMENI SYNDROME
por: Kibe, Yuji, et al.
Publicado: (2022)

CD79B Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma
por: Yamaguchi, Junya, et al.
Publicado: (2022)

Assessment of Tumor Cells in a Mouse Model of Diffuse Infiltrative Glioma by Raman Spectroscopy
por: Tanahashi, Kuniaki, et al.
Publicado: (2014)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas
por: Aoki, Kosuke, et al.
Publicado: (2021)

Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
por: Kibe, Yuji, et al.
Publicado: (2023)

Aberrant Transcriptional Regulation of Super-enhancers by RET Finger Protein-histone Deacetylase 1 Complex in Glioblastoma: Chemoresistance to Temozolomide
por: NATSUME, Atsushi, et al.
Publicado: (2019)

Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review
por: Maeda, Osamu, et al.
Publicado: (2020)

Current Trends in Targeted Therapies for Glioblastoma Multiforme
por: Ohka, Fumiharu, et al.
Publicado: (2012)

ML-9 TREATMENT OUTCOMES OF TIRABRUTINIB FOR RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IN A SINGLE INSTITUTE
por: Ohka, Fumiharu, et al.
Publicado: (2022)

Supratotal Resection of Gliomas With Awake Brain Mapping: Maximal Tumor Resection Preserving Motor, Language, and Neurocognitive Functions
por: Motomura, Kazuya, et al.
Publicado: (2022)

Rapid detection of the MYD88 L265P mutation for pre‐ and intra‐operative diagnosis of primary central nervous system lymphoma
por: Yamaguchi, Junya, et al.
Publicado: (2023)

(11)C-methionine- and (18)F-FDG-PET double-negative metastatic brain tumor from lung adenocarcinoma with paradoxical high (18)F-FDG uptake: A case report
por: Tanahashi, Kuniaki, et al.
Publicado: (2022)

Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury
por: Nagashima, Yoshitaka, et al.
Publicado: (2021)

Direct intracranial invasion of eccrine spiradenocarcinoma of the scalp: a case report and literature review
por: Kibe, Yuji, et al.
Publicado: (2022)

An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas
por: Yamamichi, Akane, et al.
Publicado: (2016)

Navigated repetitive transcranial magnetic stimulation as preoperative assessment in patients with brain tumors
por: Motomura, Kazuya, et al.
Publicado: (2020)

Double-edged Sword in the Placement of Carmustine (BCNU) Wafers along the Eloquent Area: A Case Report
por: Kuramitsu, Shunichiro, et al.
Publicado: (2014)

The Global DNA Methylation Surrogate LINE-1 Methylation Is Correlated with MGMT Promoter Methylation and Is a Better Prognostic Factor for Glioma
por: Ohka, Fumiharu, et al.
Publicado: (2011)

LGG-56. INFANTILE HEMISPHERIC BRAIN TUMOR WITH A GOPC-ROS1 FUSION GENE: A CASE REPORT
por: Taniguchi, Rieko, et al.
Publicado: (2020)

Epigenetic dysregulation in glioma
por: Kondo, Yutaka, et al.
Publicado: (2014)

Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab: illustrative case
por: Ohno, Masasuke, et al.
Publicado: (2022)

Dural Arteriovenous Fistula Mimicking a Brain Tumor on Methionine-positron Emission Tomography: A Case Report
por: HANYU, Taketo, et al.
Publicado: (2022)

Recent Molecular and Genetic Findings in Intramedullary Spinal Cord Tumors
por: Nagashima, Yoshitaka, et al.
Publicado: (2022)

All-in-One Nanowire Assay System for Capture and Analysis of Extracellular Vesicles from an ex Vivo Brain Tumor Model
por: Chattrairat, Kunanon, et al.
Publicado: (2023)

Complete Radiologic Response in an Anaplastic Oligodendroglioma Treated with Temozolomide and Bevacizumab
por: Katz, Artur, et al.
Publicado: (2009)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013)

Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab
por: Tamura, Ryota, et al.
Publicado: (2020)

ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma
por: Shi, Ying, et al.
Publicado: (2021)

Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years
por: Ohno, Makoto, et al.
Publicado: (2019)

Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
por: Shields, Lisa BE, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_f8aniu55p4v7nnhinmteoi5pqe